Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 618 results for "cadila healthcare"

Zydus completes Phase I trials of anaemia drug
Business Standard India

Zydus completes single rising dose Phase I studies for its ora...

Cadila Healthcare Ltd has informed BSE regarding a Press Release dated February 16, 2015 titled " for treating Anemia and initiates multiple dosing studies".Source : BSE Read all announcements in Cadila Health To read the full report, 2 weeks ago
Cadila Healthcare announces resignation of director Business Standard, 2 months ago

7 images for cadila healthcare, 2 weeks ago
India Infoline, 3 weeks ago
Business Standard India, 3 weeks ago, 2 weeks ago
India Infoline, 4 weeks ago
Business Standard, 1 month ago
Business Standard, 1 month ago

Cadila Healthcare 3QFY2015 performance highlights and results update

thcare's 3QFY2015 results came in much higher than estimated. Sales growth for 3QFY2015 came in at 17.5% yoy, to end the period at Rs.2,160cr V/s Rs.2,080cr expected and V/s Rs.1,838cr in 3QFY2014.On the operating front, the OPM came in at 19.3% V/s ...
 Stock Markets Review2 weeks ago
Eurasia Review

Natco, Gilead sign deal for hepatitis-C medicines

Indian drugmaker Natco Pharma has collaborated with Gilead Sciences to manufacture and sell copycat versions of their hepatitisC medicines, after having opposed the US company from getting a patent for Sovaldi in India. There already are around ...
 Financial Chronicle9 hours ago Examining The Gilead Deal Analysis  Eurasia Review1 week ago Gileadexpands alliance with Indian partners to include investigational drug  Hindu Business Line1 month ago Gilead élargit ses accords de licence sur la version générique contre l'hépatite C en incluant un agent pan-génotypique  Quoteline1 month ago

Lots in a name, if it is Gujarat

If as a stock market punter you had foreseen Narendra Modi coming to power at the start of 2014 and made your equity choices accordingly, it's a pretty pile of cash youd be sitting on now. The Modi stocks listed companies seen as having an in with ...
 Hindu Business Line2 days ago

Top sectoral, stock gainers since previous Budget

MUMBAI: The bulls were back in the market and the Sensex surged almost 500 points after the Economic Survey indicated that India has reached a sweet spot and is on track to achieve double-digit growth. It has been 'Acche Din' for the Indian market ...
 Economic Times3 days ago

Global Treatments for Syndromes of Progressive Ataxia and Weakness Disorders Market - Industry Size, Trends, Growth Analysis and Forecast to 2020

Persistence Market Research is released upcoming report on title "Treatments for Syndromes of Progressive Ataxia and Weakness Disorders - Global Industry Analysis and Forecast to 2020". New York, NY -- (ReleaseWire) -- 02/27/2015 -- Ataxia is a ...
 Digital Journal3 days ago

Gilead Taking Giant Leap To Serve The Hepatitis C Market Of Developing Countries

U.S.-based drug firm Gilead Sciences ( GILD ) has been a pioneer in the introduction of drugs like Sovaldi and Harvoni for the treatment of hepatitis C-infected patients in the developed countries. Currently, the drug giant is focusing on extending ...
 Guru Focus4 days ago Armed with Indian approval, Gilead forges ahead with Sovaldi and its licensed copies  FiercePharma1 month ago Gilead Expands Generic Sovaldi Pact to Add Investigational Pill  BusinessWeek1 month ago

Global Strongyloidiasis Therapeutics Clinical Trials Market H2 2014 Review Research Report

/PRNewswire/ -- adds "Strongyloidiasis Global Clinical Trials Review, H2, 2014" market research report to its store. This report provides data on the Strongyloidiasis clinical trial scenario. The clinical trial report " ...
 Crawford Financial Planning5 days ago

India Pharma Outlook 2015: Accelerating growth to the next level: Moving up the value chain beyond Generics

Domestic sales improved in 2014, recovering from the slump in the 2013 caused by the market's reaction to the new drug pricing policy. In 2015, growth is expected to continue to be healthy, as the momentum continues and improving economic growth ...
 Global Information Inc4 days ago

Bharat Biotech working on stronger swine flu vaccine: chairman

An estimated 11,000 swine flu cases have been reported across India in the last three months, resulting in more than 800 deaths. Photo: PTI Hyderabad: Bharat Biotech International Ltd has started work on developing a more potent vaccine for swine ...
 Livemint.com6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cadila healthcare
Get updated on latest news & your favorite topics right in your inbox!
More     Less